Table 1. Patients demographics for MBC study population.
| Nottingham City Hospital, UK ( N =12) | Soroka University Hospital, Israel ( N =26) | |
|---|---|---|
| Age | 51 (36–76) | 55 (30–80) |
| Female | 12 | 25 |
| Male | --- | 1 |
| Weight | 64 (45–80) | 68 (45–98) |
| Height | 162 (150–170) | 160 (148–175) |
| Ethnic group | Caucasians | Caucasians |
| Docetaxel treatment duration (days) | 152 (114–274) | 106 (38–354) |
| Treatment regimen | Q21Da | Q21D or Q7Da |
| Dose (mg m−2) | 100 (67.5–100) | 36 (23–101) |
Abbreviations: MBC=metastatic breast cancer; Q21D=docetaxel administered every 3 weeks; Q7D=docetaxel administered every 7 days.
a
Annals of Oncologyannonc.oxfordjournals.org